Targovax - Articles and news items

RAS

Targovax initiates clinical immunotherapy trial to treat RAS-mutated cancer

Industry news / 20 April 2017 / Niamh Marriott, Junior Editor

Targovax has recruited the first patient in an exploratory Phase Ib clinical trial of TG02 in patients with locally recurrent RAS-mutated rectal cancer…

Targovax submits study protocol for ONCOS-102 to Spanish authorities

Industry news / 2 February 2016 / Victoria White

Targovax has submitted a study protocol to the regulatory authorities in Spain to assess ONCOS-102 in patients with malignant pleural mesothelioma…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+